Novakova Iveta, Subileau Eva-Anne, Toegel Stefan, Gruber Daniela, Lachmann Bodo, Urban Ernst, Chesne Christophe, Noe Christian R, Neuhaus Winfried
Department of Medicinal Chemistry, University of Vienna, Vienna, Austria.
Biopredic International, Rennes, France.
PLoS One. 2014 Jan 23;9(1):e86806. doi: 10.1371/journal.pone.0086806. eCollection 2014.
The aim of this work was to conduct a comprehensive study about the transport properties of NSAIDs across the blood-brain barrier (BBB) in vitro. Transport studies with celecoxib, diclofenac, ibuprofen, meloxicam, piroxicam and tenoxicam were accomplished across Transwell models based on cell line PBMEC/C1-2, ECV304 or primary rat brain endothelial cells. Single as well as group substance studies were carried out. In group studies substance group compositions, transport medium and serum content were varied, transport inhibitors verapamil and probenecid were added. Resulted permeability coefficients were compared and normalized to internal standards diazepam and carboxyfluorescein. Transport rankings of NSAIDs across each model were obtained. Single substance studies showed similar rankings as corresponding group studies across PBMEC/C1-2 or ECV304 cell layers. Serum content, glioma conditioned medium and inhibitors probenecid and verapamil influenced resulted permeability significantly. Basic differences of transport properties of the investigated NSAIDs were similar comparing all three in vitro BBB models. Different substance combinations in the group studies and addition of probenecid and verapamil suggested that transporter proteins are involved in the transport of every tested NSAID. Results especially underlined the importance of same experimental conditions (transport medium, serum content, species origin, cell line) for proper data comparison.
这项工作的目的是在体外对非甾体抗炎药(NSAIDs)通过血脑屏障(BBB)的转运特性进行全面研究。使用塞来昔布、双氯芬酸、布洛芬、美洛昔康、吡罗昔康和替诺昔康,基于细胞系PBMEC/C1-2、ECV304或原代大鼠脑内皮细胞,通过Transwell模型完成了转运研究。进行了单物质以及组物质研究。在组物质研究中,改变了物质组组成、转运介质和血清含量,并添加了转运抑制剂维拉帕米和丙磺舒。将得到的渗透系数与内标地西泮和羧基荧光素进行比较并归一化。获得了NSAIDs在每个模型中的转运排名。单物质研究显示,在PBMEC/C1-2或ECV304细胞层上,其排名与相应的组物质研究相似。血清含量、胶质瘤条件培养基以及抑制剂丙磺舒和维拉帕米对所得渗透率有显著影响。比较所有三种体外血脑屏障模型,所研究的NSAIDs转运特性的基本差异相似。组物质研究中的不同物质组合以及丙磺舒和维拉帕米的添加表明,转运蛋白参与了每种测试NSAID的转运。结果特别强调了相同实验条件(转运介质、血清含量、物种来源、细胞系)对于进行正确数据比较的重要性。